Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination

Vaccine

Volumn 33, Issue 38, 2015, Pages 4850-4857

  Baum, Ulrike ^a   Leino, Tuija ^a   Gissler, Mika ^a   Kilpi, Terhi ^a   Jokinen, Jukka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Pandemic influenza A(H1N1); Perinatal health; Perinatal survival; Pregnancy; Trimester; Vaccination; Vaccine safety

Indexed keywords

INFLUENZA VACCINE; ALPHA TOCOPHEROL; ASO3B ADJUVANT; DRUG COMBINATION; POLYSORBATE; SQUALENE;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FINLAND; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NEWBORN DEATH; PANDEMIC INFLUENZA; PERINATAL PERIOD; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; STILLBIRTH; SURVIVAL; VERY LOW BIRTH WEIGHT; ADOLESCENT; CHEMICALLY INDUCED; CHILD HEALTH; DRUG COMBINATION; IMMUNIZATION; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); NEWBORN; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA-TOCOPHEROL; DRUG COMBINATIONS; FEMALE; FINLAND; HUMANS; IMMUNIZATION SCHEDULE; INFANT HEALTH; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; POLYSORBATES; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RETROSPECTIVE STUDIES; SQUALENE; STILLBIRTH; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84940725753     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.07.061     Document Type: Article

References (36)

1. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359(15 (Oct)):1555-1564. [9].
2. Skowronski D.M., De Serres G. Is routine influenza immunization warranted in early pregnancy?. Vaccine 2009, 27(35 (Jul)):4754-4770. [30].
3. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8(5 (May)):e1000441.
4. Steinhoff M.C., Omer S.B., Roy E., El Arifeen S., Raqib R., Dodd C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012, 184(6 (Apr)):645-653. [3].
5. Rohner G.B., Meier S., Bel M., Combescure C., Othenin-Girard V., Swali R.A., et al. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J 2013, (Sep). [20].
6. Ng S., Wu P., Nishiura H., Ip D.K., Lee E.S., Cowling B.J. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11. BMC Infect Dis 2011, 11(230 (Aug)). [2334-11-230, 26].
7. Mereckiene J., Cotter S., Nicoll A., Lopalco P., Noori T., Weber J., et al. Seasonal influenza immunisation in Europe overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill 2014, 19(16 (Apr)):20780. [24].
8. Henninger M., Naleway A., Crane B., Donahue J., Irving S. Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol 2013, 121(4 (Apr)):741-749.
9. Wiley K.E., Massey P.D., Cooper S.C., Wood N.J., Ho J., Quinn H.E., et al. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Med J Aust 2013, 198(7 (Apr)):373-375. [15].
10. Yuen C.Y., Tarrant M. Determinants of uptake of influenza vaccination among pregnant women-a systematic review. Vaccine 2014, 32(36 (Aug)):4602-4613. [6].
11. Harper S.A., Fukuda K., Uyeki T.M., Cox N.J., Bridges C.B. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004, 53(RR-6 (May)):1-40. [28].
12. Heikkinen T., Young J., van Beek E., Franke H., Verstraeten T., Weil J.G., et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012, 207(3 (Sep)):177e1-177e8.
13. Rubinstein F., Micone P., Bonotti A., Wainer V., Schwarcz A., Augustovski F., et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ 2013, 346:f393. [Feb 4].
14. Trotta F., Da Cas R., Spila Alegiani S., Gramegna M., Venegoni M., Zocchetti C., et al. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014, 348:g3361. [May 29].
15. Sammon C.J., Snowball J., McGrogan A., de Vries C.S. Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS One 2012, 7(12 (Dec)):e51734. [20].
16. Ludvigsson J.F., Zugna D., Cnattingius S., Richiardi L., Ekbom A., Ortqvist A., et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol 2013, 28(7 (Jul)):579-588.
17. Pasternak B., Svanstrom H., Molgaard-Nielsen D., Krause T.G., Emborg H.D., Melbye M., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012, 344:e2794. [May 2].
18. Pasternak B., Svanstrom H., Molgaard-Nielsen D., Krause T.G., Emborg H.D., Melbye M., et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012, 308(2 (Jul)):165-174. [11].
19. Kallen B., Olausson P.O. Vaccination against H1N1 influenza with Pandemrix((R)) during pregnancy and delivery outcome: a Swedish register study. BJOG 2012, 119(13 (Dec)):1583-1590.
20. Haberg S.E., Trogstad L., Gunnes N., Wilcox A.J., Gjessing H.K., Samuelsen S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013, 368(4 (Jan)):333-340. [24].
21. Sankilampi U., Hannila M.L., Saari A., Gissler M., Dunkel L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med 2013, 45(5-6 (Sep)):446-454.
22. Andridge R.R., Little R.J. A review of hot deck imputation for survey non-response. Int Stat Rev 2010, 78(1 (Apr)):40-64.
23. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effect. Biometrika 1983, 70(1):41-55.
24. Sturmer T., Rothman K.J., Avorn J., Glynn R.J. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution-a simulation study. Am J Epidemiol 2010, 172(7 (Oct)):843-854. [1].
25. Cox D.R. Regression models life-tables. J Royal Stat Soc Ser B 1972, 34(2):187-220.
26. Lyytikainen O., Kuusi M., Snellman M., Virtanen M., Eskola J., Ronkko E., et al. Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009-8 March 2010. Euro Surveill 2011, 16(27 (Jul)):19908. [7].
27. R: A language and environment for statistical computing 2014, R Core Team, R Foundation for Statistical 354 Computing, Vienna, Austria, 〈http://www.R-project.org/〉.
28. Carstensen B, Plummer M, Laara E, Hills M. Epi: A package for statistical analysis in epidemiology, R package version 1.1.67., 〈http://CRAN.R-project.org/package=Epi〉; 2014.
29. Therneau T. A package for survival analysis in S, R package version 2.37-7, 〈http://CRAN.R-project.org/package=survival〉; 2014.
30. Gissler M., Shelley J. Quality of data on subsequent events in a routine Medical Birth Register. Med Inform Internet Med 2002, 27(1 (Mar)):33-38.
31. Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health 2012, 40(6 (Aug)):505-515.
32. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavainen T., Sundman J., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012, 7(3):e33536.
33. Flenady V., Koopmans L., Middleton P., Froen J.F., Smith G.C., Gibbons K., et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011, 377(9774 (Apr)):1331-1340. [16].
34. Lamminpaa R., Vehvilainen-Julkunen K., Gissler M., Heinonen S. Smoking among older childbearing women-a marker of risky health behaviour a registry-based study in Finland. BMC Public Health 2013, 13(1179 (Dec)). [2458-13-1179, 13].
35. Mak T.K., Mangtani P., Leese J., Watson J.M., Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008, 8(1 (Jan)):44-52.
36. Pierce M., Kurinczuk J.J., Spark P., Brocklehurst P., Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011, 342 (Jun):d3214. [14].